Samer K. Khaled

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli et al. · The Lancet Oncology · 2019 · 465 citations

Hematological Malignancy, Medicine, Hematology +5

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Xiuli Wang, Leslie Popplewell, Jamie R. Wagner et al. · Blood · 2016 · 326 citations · Full text

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

Brenda M. Sandmaier, Samer K. Khaled, Betül Oran et al. · American Journal of Hematology · 2017 · 126 citations · Full text

Gastric Hemorrhage, Mixed-phenotype Acute Leukemia, Immunology +21

SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function

Jie Sun, Xin He, Ying‐Hui Zhu et al. · Cell stem cell · 2018 · 109 citations · Full text

Progenitor Cells, Lineage Plasticity, Cell Regulation +12

Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis

Sepideh Shayani, Joycelynne Palmer, Tracey Stiller et al. · Biology of Blood and Marrow Transplantation · 2012 · 107 citations · Full text

Gvhd Prophylaxis, Immunology, Transplantation Medicine +20